ADPTQ Adeptus Health

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Adeptus Health Inc.

NEW YORK--(BUSINESS WIRE)--

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Adeptus Health Inc. (NYSE:ADPT) resulting from allegations that Adeptus Health may have issued materially misleading business information to the investing public.

On March 2, 2017, Adeptus Health revealed that it identified material weaknesses in its internal control over financial reporting related to revenue recognition, accounts receivable, accounting for a contribution to an unconsolidated joint venture, and accounting for equity in (loss) earnings of unconsolidated joint ventures. As a result, Adeptus Health is evaluating the effect of these errors in its financial statements for prior periods. On this news, shares of Adeptus Health fell sharply during intraday trading on March 2, 2017.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Adeptus Health investors. If you purchased shares of Adeptus Health on or before March 1, 2017, please visit the firm’s website at http://www.rosenlegal.com/cases-1066.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

EN
02/03/2017

Underlying

ADPTQAdeptus Health

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Adeptus Health

Free Trial
ADPTQ ADEPTUS HEALTH

Adaptive Biotechnologies Corp: 1 director

A director at Adaptive Biotechnologies Corp sold after exercising options/sold 70,000 shares at 8.530USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company'...

06/21/23 June 21, 2023 1 EN
 PRESS RELEASE
Free
ADPTQ ADEPTUS HEALTH

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Laws...

NEW YORK--(BUSINESS WIRE)-- Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Texas on behalf of all persons or entities who purchased or otherwise acquired Adeptus Health, Inc. (NYSE:ADPT) securities between April 29, 2016 and March 1, 2017 (the “Class Period”). Investors have until May 9, 2017 to apply to the Court to be appointed as lead plaintiff in the lawsuit. The Complaint alleges that throughout the Class Period, Defendants m...

May 4, 2017 1 EN
 PRESS RELEASE
Free
ADPTQ ADEPTUS HEALTH

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadli...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas on behalf of purchasers of Adeptus Health Inc. (NYSE: ADPT) (“Adeptus” or the “Company”) securities during the period between April 29, 2016 and March 1, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until May 9, 2017 to seek appointm...

April 14, 2017 1 EN
 PRESS RELEASE
Free
ADPTQ ADEPTUS HEALTH

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses I...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas on behalf of purchasers of Adeptus Health Inc. (NYSE: ADPT) (“Adeptus” or the “Company”) securities during the period between April 29, 2016 and March 1, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until May 9, 2017 to seek appointm...

March 28, 2017 1 EN
 PRESS RELEASE
Free
ADPTQ ADEPTUS HEALTH

ADPT LOSS ALERT: Rosen Law Firm Reminds Adeptus Health Inc. Investors ...

NEW YORK--(BUSINESS WIRE)-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Adeptus Health Inc. securities (NYSE:ADPT) from April 29, 2016 through March 1, 2017, both dates inclusive (the “Class Period”) of the important May 9, 2017 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Adeptus investors under the federal securities laws. To join the Adeptus class action, go to http://www.rosenlegal.com/cases-1066.html or call Phillip Kim, Esq. or Kevin...

March 17, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch